Navigation Links
Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer
Date:3/25/2019

Ambry Genetics, a Konica Minolta Company (Ambry), and leading provider of clinical and research genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., a biopharmaceutical company which shares Ambry’s commitment to advancing precision medicine for cancer. Through this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to identify clinical trial patients who may benefit from Rubraca®, a therapy currently approved in the U.S. and Europe in multiple advanced ovarian cancer settings.

Approximately 10 to 15% of ovarian cancer diagnoses are based on hereditary mutations of BRCA, meaning they are directly linked to mutations in the BRCA1 or BRCA2 genes passed on from a parent. Ambry’s genetic tests can identify mutations in these two genes, as well as related genes involved in the DNA repair pathway, thus enabling identification of potential risk, earlier diagnosis and more precise treatment.

"We are very excited to be working with the Clovis team, which is aligned with our precision medicine initiatives,” said Brigette Tippin Davis, Ph.D., FACMG, Senior Vice President of Research & Development of Ambry Genetics, Inc. “Our mission is to help identify patients eligible for optimal therapies to improve outcomes and enhance quality of life.”

Clovis chose to perform retrospective BRCA testing with Ambry Genetics, a high-quality genetics lab positioned to become a key player in the precision medicine space.

About Ambry Genetics
Ambry Genetics is a leader in clinical diagnostic and software solutions, combining both to offer comprehensive and high quality genetic testing. As part of the Konica Minolta family, Ambry Genetics is responsibly applying new technologies to the molecular diagnostics market to bring about precision medicine. Founded in 1999, Ambry Genetics has longstanding expertise in clinical genetic testing. For more information about Ambry Genetics, visit ambrygen.com.

Press Contact:
Jackie Copp
press(at)ambrygen(dot)com
480-606-8180

Read the full story at https://www.prweb.com/releases/ambry_genetics_to_develop_custom_assays_targeted_to_patients_with_hereditary_ovarian_cancer/prweb16160917.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting
2. Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services
3. ACMG Annual Clinical Genetics Meeting Named One of the Fastest Growing Meetings in USA for Fourth Time
4. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
5. Seven researchers awarded for work presented at yeast genetics conference
6. ASHG and NHGRI award genetics and public policy fellowship
7. ASHG and NHGRI award first genetics and education fellowship
8. MARC travel awards announced for: American Society of Human Genetics 2014 Annual Meeting
9. MARC travel awards announced for GSA: Mouse Molecular Genetics Conference
10. American Society of Human Genetics 2014 Annual Meeting
11. Behind the scenes of genetics, leukemia in Down syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2020)... , ... June 08, 2020 , ... ... masks and other protective measures to protect workers in the medical field. The ... dedicated staffs who valiantly risk their lives every day to provide healthcare to ...
(Date:6/5/2020)... ... June 04, 2020 , ... “Although we are disappointed to ... of our attendees, staff, and the public. We remain committed to creating a ... to collaborate virtually,” said Julie Sutcliffe, President of WMIS. , The ...
(Date:5/30/2020)... SAN JOSE, Calif. (PRWEB) , ... May 29, ... ... services and enabler of digital transformation for enterprises globally, has collaborated with EchoNous ... by the FDA. It can measure systolic heart function, which has been ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... June 22, 2020 ... ... products, is now offering an Amniosomes special offer. This includes buy three, get ... providers should call (888) 568-6909. , Amniotic derived exosomes, known as exosomes, have ...
(Date:6/23/2020)... PORTLAND, Ore. (PRWEB) , ... June 23, 2020 ... ... advancement of innovative CNS therapies, today announced that it has filed an Investigational ... initiate a Phase 2b clinical trial of its lead drug candidate NBTX-001 in ...
(Date:6/11/2020)... ... 08, 2020 , ... Greffex, a leading genetic engineering company, ... clean viral vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies ... world’s most successful gene therapy delivery vehicle (vector) with broad applications for delivering ...
(Date:6/11/2020)... GREENBELT, Md. (PRWEB) , ... June 09, 2020 ... ... announced today the release of the NEON Micro-Tracer Solution, a highly ... to the COVID-19 virus in the workplace. Contact tracing, a core disease control ...
Breaking Biology Technology: